Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Brain tumor, adult: Meningioma/Meningeal tumors
Country:  U.S.A.
Trial Type:  Treatment
Results 1-10 of 10 for your search:
Start Over
Bendamustine Hydrochloride in Treating Patients with Recurrent or Progressive Anaplastic Glioma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 6803, NCI-2010-00714, UWCC-6803, FHCRC-6803, IR-6803, NCCN-C01, NCT00823797
Proton Beam Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma or Hemangiopericytoma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 24309, NCI-2010-01084, NCT01117844
Laboratory Treated T-Cells in Treating Patients with NY-ESO-1 Expressing Metastatic or Locally Advanced Recurrent Solid Tumors or Malignant Meningioma
Phase: Phase II
Type: Treatment
Age: 18 to 66
Trial IDs: 13-C-0214, NCI-2015-00137, 130214, 1308-1249, P131300, RD-13-VII-07, NCT01967823
Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 11D.100, NCI-2011-02346, 2010-38, NCT01324635
Dexanabinol in Treating Patients With Recurrent Brain Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: SK01-ETS2101, NCI-2012-01204, 111827, NCT01654497
Temozolomide and Ascorbic Acid in Treating Patients with Recurrent High-Grade Glioma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: 735-13, NCI-2014-01061, NCT02168270
Vaccine Therapy in Treating Patients With Recurrent Gliomas After Surgery
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 08-135, NCI-2011-02491, NCT00874861
Conditioning Therapy Followed by Stem Cell Transplant in Treating Patients with High Risk or Relapsed Solid or Central Nervous System Tumors
Phase: No phase specified
Type: Treatment
Age: 70 and under
Trial IDs: 2011OC057, NCI-2013-02265, 1107M02641, MT2011-09C, NCT01505569
Everolimus in Patients with Vestibular Schwannomas or Meningiomas Undergoing Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NYU S12-02808, NCI-2013-01174, 13211666, i12-02808, S12-02808, NCT01880749
Electric Field Therapy in Treating Patients with Recurrent Meningioma
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 13-067, NCI-2013-01316, NCT01892397
Start Over